IL17A and rheumatoid arthritis: The findings reveal significant differences in multiple clinical and laboratory parameters, immune cell composition, and cytokine levels between the RA-obstructive CAD and RA-non-obstructive CAD groups, particularly in the elevated inflammatory markers CRP, Th17 cells, and IL-17.